Albemarle Corp
NYSE: ALB · BASIC MATERIALS · SPECIALTY CHEMICALS
Updated 2026-04-29
Albemarle Corp (ALB) Financial Forecast & Price Target 2030
Research-backed projections from analyst consensus, management guidance, and sector analysis.
Price target summary
Management guidance
No specific revenue guidance found in available data. CEO J. Kent Masters recently sold shares, indicating focus on balance sheet management rather than aggressive growth guidance. Company is executing debt tender offers and cost discipline initiatives, suggesting near-term focus on operational efficiency and margin improvement rather than top-line expansion.
Revenue & price projection
Financial forecast — research-backed
| Metric | 2023 | 2024 | 2025 | 2026 (E) | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.6B | $5.4B | $5.1B | $5.7B | $6.0B | $6.8B | $7.7B | $8.5B |
| Revenue growth | — | -44.1% | -4.4% | 10.7% | 5.9% | 13.6% | 12.1% | 11.2% |
| EPS | $22.24 | $-2.34 | $-0.79 | $7.52 | $8.83 | $10.50 | $11.85 | $13.20 |
| P/S ratio | — | — | — | 12.0x | 12.0x | 12.0x | 12.0x | 12.0x |
| Implied price | — | — | — | $571.00 | $588.30 | $674.82 | $761.33 | $847.85 |
Catalysts & risks
Methodology
Albemarle Corp's forward estimates are derived from AI-powered research synthesis combining analyst consensus from 21 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts from industry research. Revenue and EPS projections use analyst consensus where available and conservative extrapolation with growth deceleration for outer years. Price targets are calculated using a tiered Price-to-Sales (P/S) methodology, where the P/S multiple is determined by the projected revenue growth rate.
WallStSmart proprietary research model · Not financial advice · Past performance is not indicative of future results · Last researched: April 7, 2026.